To study the time-course relationship between vascular functions and endoplasmic reticulum (ER) stress in type 2 diabetes, we investigated vascular function and associated protein expression, including cyclo-oxygenase (COX), ER stress, and apoptotic markers, in renal arteries (RA) from type 2 diabetic Otsuka Long-Evans Tokushima fatty (OLETF) rats at the young adult (4 months old) and aged (18 months old) stages. In the RA of aged OLETF (vs. young OLETF), we found: (1) Increased contractions induced by uridine adenosine tetraphosphate (Up4A) and phenylephrine, (2) decreased relaxation and increased contraction induced by acetylcholine (ACh) at lower and higher concentrations, respectively, and (3) increased expression of COX-1 and C/EBP-homologous protein (CHOP, a pro-apoptotic protein). In aged rats, the expression of COX-1, COX-2, PDI (an ER protein disulfide isomerase), Bax (a proapoptotic marker), and CHOP were increased in RA from OLETF rats (vs. age-matched control Long-Evans Tokushima Otsuka [LETO] rats). Up-regulation of PDI and Bax were seen in the RA from young OLETF (vs. young LETO) rats. No age-related alterations were apparent in the above changes in RA from LETO rats, excluding ACh-induced contraction. Short-term treatment with the ER stress inhibitor tauroursodeoxycholic acid (TUDCA, 100 mg/kg per day, intraperitoneally for 1 week) to OLETF rats at the chronic stage of the disease (12 months old) could suppress renal arterial contractions induced by Up4A and ACh. These results suggest that a long-term duration of disease may be important for the development of vascular dysfunction rather than aging per se. The early regulation of ER stress may be important against the development of diabetes-associated vascular dysfunction.
WangF, ChenHZ, LvX, LiuDP. SIRT1 as a novel potential treatment target for vascular aging and age-related vascular diseases. Curr Mol Med, 2013; 13:155–164.
3.
RadovitsT, GeroD, LinLN, LoganathanS, Hoppe-TichyT, SzaboC, KarckM, SakuraiH, SzaboG. Improvement of aging-associated cardiovascular dysfunction by the orally administered copper(II)-aspirinate conmplex. Rejuvenation Res, 2008; 11:945–956.
4.
TakenouchiY, KobayashiT, MatsumotoT, KamataK. Gender differences in age-related endothelial function in the murine aorta. Atherosclerosis, 2009; 206:397–404.
5.
FeletouM, HuangY, VanhouttePM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol, 2011; 164:894–912.
6.
Carrillo-SepulvedaMA, MatsumotoT, NunesKP, WebbRC. Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy. Acta Physiol, 2014; 211:20–35.
7.
SenaCM, PereiraAM, SeicaR. Endothelial dysfunction—a major mediator of diabetic vascular disease. Biochim Biophys Acta, 2013; 1832:2216–2231.
8.
BartonM. Obesity and aging: Determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch, 2010; 460:825–837.
9.
VanhouttePM, TangEH. Endothelium-dependent contractions: When a good guy turns bad! J Physiol. 2008; 586:5295–5304.
10.
MatsumotoT, NakayamaN, IshidaK, KobayashiT, KamataK. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J Pharmacol Exp Ther, 2009; 329:324–334.
11.
MatsumotoT, KakamiM, NoguchiE, KobayashiT, KamataK. Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol, 2007; 293:H1480–H1490.
12.
MatsumotoT, NoguchiE, IshidaK, KobayashiT, YamadaN, KamataK. Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol, 2008; 295:H1165–H1176.
13.
RonD, WalterP. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol, 2007; 8:519–529.
14.
NaidooN. ER and aging—Protein folding and the ER stress response. Aging Res Rev, 2009; 306:150–159.
15.
TabasI, RonD. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol, 2011; 13:184–190.
16.
HotamisligilGS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell, 2010; 140:900–917.
17.
HummastiS, HotamisligilGS. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ Res, 2010; 107:579–591.
OzcanU, YilmazE, OzcanL, FuruhashiM, VailancourtE, SmithRO, GorgunCZ, HotamisligilGS. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science, 2006; 313:1137–1140.
20.
MaJH, WangJJ, ZhangSX. The unfolded protein response and diabetic retinopathy. J Diabetes Res, 2014; 2014:160140.
21.
CunardR, SharmaK. The endoplasmic reticulum stress response and diabetic kidney disease. Am J Physiol Renal Physiol, 2011; 300:F1054–F1061.
22.
ZhuangA, ForbesJM. Stress in the kidney is the road to pERdition: Is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy?. J Endocrinol, 2014; 222:R97–R111.
23.
SpitlerKM, MatsumotoT, WebbRC. Suppression of endoplasmic reticulum stress improves endothelium-dependent contractile responses in aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol, 2013; 305:H344–H353.
24.
KassanM, GalanM, PartykaM, SaifudeenZ, HenrionD, TrebakM, MatrouguiK. Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice. Arterioscler Thromb Vasc Biol, 2012; 32:1652–1661.
25.
SpitlerKM, WebbRC. Endoplasmic reticulum stress contributes to aortic stiffening via proapoptotic and fibrotic signaling mechanisms. Hypertension, 2014; 63:e40–e45.
26.
PadillaJ, JenkinsNT. Induction of endoplasmic reticulum stress impairs insulin-stimulated vasomotor relaxation in rat aortic rings: Role of endothelin-1. J Physiol Pharmacol, 2013; 64:557–564.
27.
JankowskiV, TolleM, VanholderR, SchonfelderG, van der GietM, HenningL, SchluterH, PaulM, ZidekW, JankowskiJ. Uridine adenosine tetraphosphate: A novel endothelium-derived vasoconstrictive factor. Nat Med, 2005; 11:223–227.
28.
JankowskiV, MeyerAA, SchlattmannP, GuiY, ZhengXL, StamcouI, RadtkeK, TranTN, van der GietM, TolleM, ZidekW, JankowskiJ. Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives. Arterioscler Thromb Vasc Biol, 2007; 27:1776–1781.
29.
MatsumotoT, TostesRC, WebbRC. The role of uridine adenosine tetraphosphate in the vascular system. Adv Pharmacol Sci, 2011; 2011:435132.
30.
SchuchardtM, PruferJ, PruferN, WiedonA, HuangT, ChebliM, JankowskiV, JankowskiJ, Schafer-KortingM, ZidekW, van der GietM, TolleM. The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. J Mol Med, 2011; 89:799–810.
31.
MatsumotoT, TostesRC, WebbRC. Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol, 2011; 301:H409–H417.
32.
MatsumotoT, TostesRC, WebbRC. Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats. Pharmacol Res, 2012; 65:81–90.
33.
MatsumotoT, WatanabeS, KawamuraR, TaguchiK, KobayashiT. Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis. Pflugers Arch, 2014; 466:331–342.
KagotaS, YamaguchiY, NakamuraK, KunitomoM. Altered endothelium-dependent responsiveness in the aortas and renal arteries of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of noninsulin-dependent diabetes mellitus. Gen Pharmacol, 2000; 34:201–209.
36.
TakatoriS, FujiwaraH, ZamamiY, Hashikawa-HobaraN, KawasakiH. Decreased perivascular CGRP-containing nerves in Otsuka Long-Evans Tokushima Fatty rats with insulin resistance and hypertension. Hypartens Res, 2014; 37:398–404.
37.
MatsumotoT, WatanabeS, TaguchiK, KobayashiT. Mechanisms underlying increased serotonin-induced contraction in carotid arteries from chronic type 2 diabetic Goto-Kakizaki rats. Pharmacol Res, 2014; 87:123–132.
38.
PannirselvamM, WiehlerWB, AndersonT, TriggleCR. Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products. Br J Pharmacol, 2005; 144:953–960.
Castillo-HernandezMC, Guevara-BalcazarG, Lopez-SanchezP, Asbun-BojalilJ, LopezRM, CastilloEF, Castillo-HenkelC. The influence of constitutive COX-2 in smooth muscle tissue on the contractile effect of phenylephrine in the rat abdominal aorta. Front Biosci, 2010; 2:441–448.
41.
LinLL, WartmannM, LinAY, KnopfJL, SethA, DavisRJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell, 1993; 72:269–278.
42.
JaronenM, GoldsteinsG, KoistinahoJ. ER stress and unfolded protein response in amyotrophic lateral sclerosis—a controversial role of protein disulphide isomerase. Front Cell Neurosci, 2014; 8:402.
43.
GrekC, TownsendDM. Protein disulfide isomerase superfamily in disease and the regulation of apoptosis. Endoplasmic Reticulum Stress Dis, 2014; 1:4–17.
44.
OyadomariS, MoriM. Role of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ, 2004; 11:381–389.
45.
SanoR, ReedJC. ER stress-induced cell death mechanisms. Biochim Biophys Acta, 2013; 1833:3460–3470.
46.
SalminenA, KaarnirantaK. ER stress and hormetic regulation of the aging process. Ageing Res Rev, 2010; 9:211–217.
47.
GhoshAK, GargSK, MauT, O'BrienM, LiuJ, YungR. Elevated endoplasmic reticulum stress response contributes to adipose tissue inflammation in aging. J Gerontol A Biol Sci Med Sci, 2015; 70:1320–1329.
OrimoM, MinamotoT, MiyauchiH, TatenoK, OkadaS, MoriyaJ, KomuroI. Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol, 2009; 29:889–894.
51.
KumeS, UzuT, KashiwagiA, KoyaD. SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications. Endocr Metab Immune Disord Drug Targets, 2010; 10:16–24.
52.
WangF, ChenHZ, LvX, LiuDP. SIRT1 as a novel potential treatment target for vascular aging and age-related vascular diseases. Curr Mol Med, 2013; 13:155–164.
ArunachalamG, SamuelSM, MareiI, DingH, TriggleCR. Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. Br J Pharmacol, 2014; 171:523–535.
59.
GanoLB, DonatoAJ, PashaHM, HearonCMJr, SindlerAL, SealsDR. The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction excessive superoxide production, and inflammation with aging in mice. Am J Physiol Heart Circ Physiol, 2014; 307:H1754–H1763.
60.
JungTW, LeeKT, LeeMW, KaKH. SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150. Biochem Biophys Res Commun, 2012; 422:229–232.
61.
LiY, XuS, GilesA, NakamuraK, LeeJW, HouX, DonmezG, LiJ, LuoZ, WalshK, GuarenteL, ZangM. Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J, 2011; 25:1664–1679.
MichelFS, ManGS, ManRY, VanhouttePM. Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat. Br J Pharmacol, 2008; 155:217–226.
64.
KonV, HarrisRC, IchikawaI. A regulatory role for large vessels in organ circulation endothelial cells of the main renal artery modulate intrarenal hemodynamics in the rat. J Clin Invest, 1990; 85:1728–1733.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
